BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 14532772)

  • 61. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer.
    Jensen EH; Abraham A; Jarosek S; Habermann EB; Al-Refaie WB; Vickers SA; Virnig BA; Tuttle TM
    Surgery; 2009 Oct; 146(4):706-11; discussion 711-3. PubMed ID: 19789030
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate.
    Ferreira U; Matheus WE; Nardi Pedro R; Levi D'Ancona CA; Reis LO; Stopiglia RM; Denardi F; Rodrigues Netto N; de Cássio Zequi S; da Fonseca FP; Lopes A; Cardoso Guimarães G; de Carvalho Fernandes R; Cardenuto Perez MD
    Urol Int; 2007; 79(3):200-3. PubMed ID: 17940350
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adjuvant radiation therapy in stage III node-positive uterine cancer.
    Schmid S; Hsu IC; Hu JM; Sherman AE; Osann K; Kapp DS; Chan JK
    Gynecol Oncol; 2009 Nov; 115(2):239-43. PubMed ID: 19679341
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.
    Fleischmann A; Thalmann GN; Markwalder R; Studer UE
    J Clin Oncol; 2005 Apr; 23(10):2358-65. PubMed ID: 15800327
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
    Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
    Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
    Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
    Leggett MD; Chen SL; Schneider PD; Martinez SR
    Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lymphadenectomy in bladder cancer: a review.
    Buscarini M; Josephson DY; Stein JP
    Urol Int; 2007; 79(3):191-9. PubMed ID: 17940349
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
    Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
    Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic significance of hydronephrosis in bladder cancer treated by radical cystectomy.
    Resorlu B; Baltaci S; Resorlu M; Ergun G; Abdulmajeed M; Haliloglu AH; Gogus C; Beduk Y
    Urol Int; 2009; 83(3):285-8. PubMed ID: 19829026
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy?
    Hong SK; Kwak C; Jeon HG; Lee E; Lee SE
    Urology; 2005 Apr; 65(4):697-702. PubMed ID: 15833511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer.
    Parthasarathy A; Kapp DS; Cheung MK; Shin JY; Osann K; Chan JK
    Obstet Gynecol; 2007 Dec; 110(6):1237-43. PubMed ID: 18055715
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.
    Wang SJ; Fuller CD; Kim JS; Sittig DF; Thomas CR; Ravdin PM
    J Clin Oncol; 2008 May; 26(13):2112-7. PubMed ID: 18378567
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database.
    Joslyn SA; Sirintrapun SJ; Konety BR
    Urology; 2005 Apr; 65(4):675-80. PubMed ID: 15833507
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.
    Ide H; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    Jpn J Clin Oncol; 2008 May; 38(5):360-4. PubMed ID: 18490370
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer.
    Lughezzani G; Sun M; Shariat SF; Budäus L; Thuret R; Jeldres C; Liberman D; Montorsi F; Perrotte P; Karakiewicz PI
    Cancer; 2011 Jan; 117(1):103-9. PubMed ID: 20803606
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.
    May M; Herrmann E; Bolenz C; Tiemann A; Brookman-May S; Fritsche HM; Burger M; Buchner A; Gratzke C; Wülfing C; Trojan L; Ellinger J; Tilki D; Gilfrich C; Höfner T; Roigas J; Zacharias M; Gunia S; Wieland WF; Hohenfellner M; Michel MS; Haferkamp A; Müller SC; Stief CG; Bastian PJ
    Eur Urol; 2011 May; 59(5):712-8. PubMed ID: 21296488
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
    Hellenthal NJ; Hussain A; Andrews PE; Carpentier P; Castle E; Dasgupta P; Kaouk J; Khan S; Kibel A; Kim H; Manoharan M; Menon M; Mottrie A; Ornstein D; Palou J; Peabody J; Pruthi R; Richstone L; Schanne F; Stricker H; Thomas R; Wiklund P; Wilding G; Guru KA
    J Urol; 2010 Jul; 184(1):87-91. PubMed ID: 20478596
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database.
    Groth SS; Virnig BA; Whitson BA; DeFor TE; Li ZZ; Tuttle TM; Maddaus MA
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):612-20. PubMed ID: 19709685
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival.
    Moore J; Hyman N; Callas P; Littenberg B
    Surgery; 2010 Mar; 147(3):358-65. PubMed ID: 19962166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.